Provided by Tiger Trade Technology Pte. Ltd.

Rani Therapeutics Holdings

0.8800
+0.02903.41%
Post-market: 0.8670-0.0130-1.48%19:38 EDT
Volume:708.40K
Turnover:622.71K
Market Cap:122.67M
PE:-4.05
High:0.8974
Open:0.8787
Low:0.8600
Close:0.8510
52wk High:3.87
52wk Low:0.4404
Shares:139.40M
Float Shares:85.67M
Volume Ratio:0.58
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2174
EPS(LYR):-0.4500
ROE:-172.15%
ROA:-52.99%
PB:3.13
PE(LYR):-1.96

Loading ...

Chardan Initiates Rani Therapeutics Holdings at Buy With $6 Price Target

MT Newswires Live
·
Aug 18

Emmaus Life Sciences Q2 Revenue Soars on Licensing Deal

Reuters
·
Aug 15

Inflammation Drug Developer HCW Biologics' Q2 Net Loss Widens

Reuters
·
Aug 15

VistaGen Q1 Revenue Rises on Licensing Agreement Expiration

Reuters
·
Aug 14

Rani Therapeutics Q2 FY26 Net Loss Narrows to USD 8.42 Million; Revenue Turns to USD 1.71 Million

Reuters
·
Aug 14

Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update

THOMSON REUTERS
·
Aug 14

Rani Therapeutics Q2 Operating Expenses USD 10.536 Million

THOMSON REUTERS
·
Aug 14

Rani Therapeutics to Present at Canaccord Genuity Annual Growth Conference

Reuters
·
Aug 10

Rani Therapeutics Names Michelle Gilson to Board as Audit Committee Chair

Reuters
·
Aug 04

Rani Therapeutics Appoints Michelle Gilson to Board of Directors

THOMSON REUTERS
·
Aug 04

Canaccord Genuity Remains a Buy on Rani Therapeutics Holdings (RANI)

TIPRANKS
·
Jul 30

Sagimet, PNC, United Rentals, Rani, Southern Copper Insider Shake-Up

TIPRANKS
·
Jul 25

Top Insider Makes Bold Move on Rani Therapeutics Stock

TIPRANKS
·
Jul 24

Rani Therapeutics Director, 10% Owner Mir A. Imran Buys 36,000 Shares Worth $24,840

Reuters
·
Jul 24

Rani Therapeutics CEO Imran Talat Acquires 35,000 Shares Worth $25,193

Reuters
·
Jul 22

Rani Therapeutics Grants CFO Nicholas Maestas Option for 2 Million Shares at $0.7 Exercise Price

Reuters
·
Jul 21

Rani Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 21

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Urogen Pharma (URGN) and vTv Therapeutics (VTVT)

TIPRANKS
·
Jul 16

Rani Therapeutics reports initial data from RT-114 study

TIPRANKS
·
Jul 15

Rani Therapeutics Says Oral Rt-114 Obesity Drug Candidate Tops Matched Injection Exposure in Phase 1a Data

Reuters
·
Jul 15